Embed this press release by copying the code below:
Biotechnology Under Consideration: MannKind Corporation (NASDAQ:MNKD), Sequenom, Inc. (NASDAQ:SQNM), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Affymax, Inc.
Biotechnology Under Consideration: MannKind Corporation (NASDAQ:MNKD), Sequenom, Inc. (NASDAQ:SQNM), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Affymax, Inc.